Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Inside the Lab Digital and computational pathology, Technology and innovation, Profession

A Boost to Brainpower

At a Glance

  • Image-based medical specialties – for example, dermatopathology – are uniquely poised to benefit from advances in augmented Intelligence (AuI)
  • AuI tools must be carefully designed and validated to minimize disruption or unintended outcomes
  • The tools must also be thoughtfully integrated into existing workflows to achieve increased efficiency and ease laboratory burden
  • Only through human-centered design around the pathologist can AuI succeed

Augmented Intelligence (AuI) has the potential to transform the clinical practice of physicians – and specialties with significant image-based components, such as radiology, dermatology, ophthalmology, and pathology, are uniquely poised to benefit from advances in deep learning applications. The concept of AuI focuses on the role of artificial intelligence (AI) in assisting clinicians. The goal? Not to replace human intelligence, but to enhance it.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Authors

Justin Ko

Clinical Associate Professor, Director, and Chief of Medical Dermatology at Stanford University, Stanford, USA.


Carrie Kovarik

Associate Professor of Medicine and Associate Professor of Dermatology at the Hospital of the University of Pennsylvania, Philadelphia, USA.

Related Application Note

Inside the Lab Oncology

Oncomine Dx Target Test – an IVD NGS solution for every lab

| Contributed by Thermo Fisher Scientific

Newsletter

Send me the latest from The Pathologist.

Sign up now

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register